CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crosby, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosby, E. T.

Canadian Journal of Anesthesia, Vol 39, 822-837, Copyright © 1992 by Canadian Anesthesiologists' Society


ARTICLES

Perioperative haemotherapy: II. Risks and complications of blood transfusion

ET Crosby
Department of Anaesthesia, Ottawa General Hospital, University of Ottawa, Ontario, Canada.

Major life-threatening complications following blood transfusion are rare and human error remains an important aetiological factor in many. The infectious risk from blood transfusion is predominantly hepatitis, and non-A, non-B and hepatitis C (HCV) are the most common subtypes noted. The risk of post-transfusion hepatitis (PTH) appears to be decreasing and this is attributed to both deferral of high-risk donors and more aggressive screening of donated blood. Screening for HCV is expected to decrease this risk further. The risk of HIV transmission following blood transfusion is negligibly small. There are data to suggest that perioperative blood transfusion results in suppression of the recipient's immune system. Earlier recurrence of cancer and an increased incidence of postoperative infection have been associated with perioperative blood transfusion although the evidence is not persuasive. Microaggregate blood filters are not recommended for routine blood transfusion but do have a role in the prophylaxis of non-haemolytic febrile reactions caused by platelet and granulocyte debris in the donor blood. Patients should be advised when there is likely to be a requirement for perioperative blood transfusion and informed consent for transfusion should be obtained.


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
G. G. Alvarez, D. A. Fergusson, D. T. Neilipovitz, and P. C. Hebert
Cell salvage does not minimize perioperative allogeneic blood transfusion in abdominal vascular surgery: a systematic review: [La recuperation de sang ne reduit pas la necessite d'une transfusion allogenique perioperatoire en chirurgie vasculaire abdominale : une revue systematique]
Can J Anesth, May 1, 2004; 51(5): 425 - 431.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. Hyllner, A. Avall, B. Swolin, J.-P. Bengtson, and A. Bengtsson
Autologous Blood Transfusion in Radical Hysterectomy With and Without Erythropoietin Therapy
Obstet. Gynecol., May 1, 2002; 99(5): 757 - 762.
[Abstract] [Full Text] [PDF]


Home page
TraumaHome page
E. M Bulger and R. V Maier
Autologous blood transfusion in trauma
Trauma, January 1, 2001; 3(1): 1 - 7.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
D. F. Szpisjak, D. S. Edgell, and B. Bissonnette
Potassium as a Surrogate Marker of Debris in Cell-Salvaged Blood
Anesth. Analg., July 1, 2000; 91(1): 40 - 43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Canadian Anesthesiologists' Society.